Evidence map›Paper›PMID 34313938›Full record

ArticleCerebellum (London, England)2022

Cognitive Decline Is Closely Associated with Ataxia Severity in Spinocerebellar Ataxia Type 2: a Validation Study of the Schmahmann Syndrome Scale.

Roberto Rodríguez-Labrada, Alejandro Batista-Izquierdo, Zuleyra González-Melix, Lorenzo Reynado-Cejas, Yaimeé Vázquez-Mojena, Yuri Arsenio Sanz, Nalia Canales-Ochoa, Yanetza González-Zaldívar, Imis Dogan, Kathrin Reetz and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Cerebellum (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 47 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Cognitive-Affective Functions of the Cerebellum.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Roberto Rodríguez-LabradaCentre for the Research and Rehabilitation of Hereditary Ataxias, Holguín, Cuba. robertrl1981@gmail.com.
Alejandro Batista-Izquierdo *Clinical & Surgical Hospital "Lucia Iñiguez", Holguín, Cuba.
Zuleyra González-Melix *Faculty of Psychology, University of Holguin, Holguin, Cuba.
Lorenzo Reynado-CejasCentre for the Research and Rehabilitation of Hereditary Ataxias, Holguín, Cuba.
Yaimeé Vázquez-MojenaCentre for the Research and Rehabilitation of Hereditary Ataxias, Holguín, Cuba.
Yuri Arsenio SanzFaculty of Psychology, University of Holguin, Holguin, Cuba.
Nalia Canales-OchoaCentre for the Research and Rehabilitation of Hereditary Ataxias, Holguín, Cuba.
Yanetza González-ZaldívarCentre for the Research and Rehabilitation of Hereditary Ataxias, Holguín, Cuba.
Imis DoganDepartment of Neurology, RWTH Aachen University, Aachen, Germany.
Kathrin ReetzDepartment of Neurology, RWTH Aachen University, Aachen, Germany.
Luis Velázquez-PérezCentre for the Research and Rehabilitation of Hereditary Ataxias, Holguín, Cuba. velazq63@gmail.com.
University of Holguín · CURWTH Aachen University · DECuban Neuroscience Center · CUUniversity of Havana · CU

Funding

bmbf, germay BMBF 01DN18022).Cuban Ministry of Public Health MINSAP-0457-2018
6 · The paper itself

Abstract

The cerebellar cognitive affective syndrome scale (CCAS-S) was designed to detect specific cognitive dysfunctions in cerebellar patients but is scarcely validated in spinocerebellar ataxias (SCA). The objective of this study is to determine the usefulness of the CCAS-S in a Cuban cohort of SCA2 patients and the relationship of its scores with disease severity. The original scale underwent a forward and backward translation into Spanish language, followed by a pilot study to evaluate its comprehensibility. Reliability, discriminant, and convergent validity assessments were conducted in 64 SCA2 patients and 64 healthy controls matched for sex, age, and education. Fifty patients completed the Montreal Cognitive Assessment (MoCA) test. The CCAS-S showed an acceptable internal consistency (Cronbach's alpha = 0.74) while its total raw score and the number of failed tests showed excellent (ICC = 0.94) and good (ICC = 0.89) test-retest reliability, respectively. Based on original cut-offs, the sensitivity of CCAS-S to detect possible/probable/definite CCAS was notably high (100%/100%/91%), but specificities were low (6%/30/64%) because the decreased specificity observed in four items. CCAS-S performance was significantly influenced by ataxia severity in patients and by education in both groups. CCAS-S scores correlated with MoCA scores, but showed higher sensitivity than MoCA to detect cognitive impairments in patients. The CCAS-S is particularly useful to detect cognitive impairments in SCA2 but some transcultural and/or age and education-dependent adaptations could be necessary to improve its diagnostic properties. Furthermore, this scale confirmed the parallelism between cognitive and motor deficits in SCA2, giving better insights into the disease pathophysiology and identifying novel outcomes for clinical trials.

Indexed as

Cerebellar AtaxiaCerebellar DiseasesCognitive DysfunctionSpinocerebellar AtaxiasAtaxiaHumansPilot ProjectsReproducibility of ResultsSyndromeCerebellar cognitive affective syndromeCerebellar cognitive affective syndrome scaleCognitive declineSpinocerebellar ataxia type 2

Identifiers

PMID34313938
OpenAlexW3183513593

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.